AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ImmunityBio, Inc. Director's Dealing 2023

Mar 2, 2023

31529_dirs_2023-03-01_26e7f9ce-7ba1-4239-b913-816f2a539007.zip

Director's Dealing

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: ImmunityBio, Inc. (IBRX)
CIK: 0001326110
Period of Report: 2021-03-09

Reporting Person: Clark Wesley (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1000	Direct

Footnotes

F1: This amendment is filed to report shares of common stock inadvertently omitted from the Form 3 filed March 11, 2021.